The impact of overdiagnosis on the selection of efficient lung cancer screening strategies.

Abstract:

:The U.S. Preventive Services Task Force (USPSTF) recently updated their national lung screening guidelines and recommended low-dose computed tomography (LDCT) for lung cancer (LC) screening through age 80. However, the risk of overdiagnosis among older populations is a concern. Using four comparative models from the Cancer Intervention and Surveillance Modeling Network, we evaluate the overdiagnosis of the screening program recommended by USPSTF in the U.S. 1950 birth cohort. We estimate the number of LC deaths averted by screening (D) per overdiagnosed case (O), yielding the ratio D/O, to quantify the trade-off between the harms and benefits of LDCT. We analyze 576 hypothetical screening strategies that vary by age, smoking, and screening frequency and evaluate efficient screening strategies that maximize the D/O ratio and other metrics including D and life-years gained (LYG) per overdiagnosed case. The estimated D/O ratio for the USPSTF screening program is 2.85 (model range: 1.5-4.5) in the 1950 birth cohort, implying LDCT can prevent ∼3 LC deaths per overdiagnosed case. This D/O ratio increases by 22% when the program stops screening at an earlier age 75 instead of 80. Efficiency frontier analysis shows that while the most efficient screening strategies that maximize the mortality reduction (D) irrespective of overdiagnosis screen through age 80, screening strategies that stop at age 75 versus 80 produce greater efficiency in increasing life-years gained per overdiagnosed case. Given the risk of overdiagnosis with LC screening, the stopping age of screening merits further consideration when balancing benefits and harms.

journal_name

Int J Cancer

authors

Han SS,Ten Haaf K,Hazelton WD,Munshi VN,Jeon J,Erdogan SA,Johanson C,McMahon PM,Meza R,Kong CY,Feuer EJ,de Koning HJ,Plevritis SK

doi

10.1002/ijc.30602

subject

Has Abstract

pub_date

2017-06-01 00:00:00

pages

2436-2443

issue

11

eissn

0020-7136

issn

1097-0215

journal_volume

140

pub_type

杂志文章
  • Expression of cholecystokinin forms by medullary thyroid cancer.

    abstract::We have studied the production and release of cholecystokinin (CCK) forms by rat medullary thyroid cancer (MTC) in vivo. MTC cells were inoculated s.c. into 8 Wag-Rij rats. One month later, after i.v. injection of calcium plasma levels of CCK, calcitonin and tissue contents of gastrin and calcitonin were determined by...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910480510

    authors: Poston GJ,Draviam EJ,Seitz PK,Rajaraman S,Alexander RW,Cooper CW,Townsend CM Jr,Thompson JC

    更新日期:1991-07-09 00:00:00

  • CHFR silencing or microsatellite instability is associated with increased antitumor activity of docetaxel or gemcitabine in colorectal cancer.

    abstract::Phenotypic differences among cancers with the same origin may be associated with chemotherapy response. CHFR silencing associated with DNA methylation has been suggested to be predictive of taxane sensitivity in diverse tumor types. However, the use of microsatellite instability (MSI:unstable-MSS:stable) as a predicti...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.28390

    authors: Pelosof L,Yerram SR,Ahuja N,Delmas A,Danilova L,Herman JG,Azad NS

    更新日期:2014-02-01 00:00:00

  • Counteracting effects of dexamethasone and alpha 2-macroglobulin on inhibition of proliferation of normal and neoplastic rat hepatocytes by transforming growth factors-beta type 1 and type 2.

    abstract::Primary cultures of hepatocytes isolated from normal F-344 rats or from F-344 rats with hepatocellular carcinomas generated by a 2-step model of chemical carcinogenesis were used to determine if dexamethasone (DEX) or alpha 2-macroglobulin (alpha 2M) modify the ability of transforming growth factors-beta type I (TGF-b...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910470223

    authors: Wollenberg GK,LaMarre J,Semple E,Farber E,Gauldie J,Hayes MA

    更新日期:1991-01-21 00:00:00

  • Real-world, population-based cohort study of toxicity and resource utilization of second-line ipilimumab for metastatic melanoma in Ontario, Canada.

    abstract::Second-line ipilimumab has been publicly funded in Ontario for metastatic melanoma (MM) since September 2012. We examined real-world toxicity of second-line ipilimumab compared to standard second-line treatments prior to funding. MM patients who received systemic treatment from April 2005 to March 2015 were included. ...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.33357

    authors: Dai WF,Beca J,Croxford R,Isaranuwatchai W,Menjak IB,Petrella TM,Mittmann N,Earle CC,Gavura S,Mercer RE,Hanna TP,Chan KKW

    更新日期:2020-10-26 00:00:00

  • Osteopontin expression in a group of lymph node negative breast cancer patients.

    abstract::The aim of this study was to examine the cellular distribution of osteopontin (OPN) protein [by immunohistochemical (IHC) analysis] and mRNA [by in situ hybridization (ISH)] in the primary tumors of lymph node negative (LNN) breast cancer patients and to determine whether the level of immunodetectable OPN may be assoc...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0215(19981023)79:5<502::aid-ijc

    authors: Tuck AB,O'Malley FP,Singhal H,Harris JF,Tonkin KS,Kerkvliet N,Saad Z,Doig GS,Chambers AF

    更新日期:1998-10-23 00:00:00

  • P-glycoprotein expression in the Golgi apparatus of multidrug-resistant cells.

    abstract::The surface and intracellular expression of mdrI-P-glycoprotein in parental drug-sensitive human breast cancer cells (MCF-7) and their multidrug-resistant (MDR) variants has been studied by using the monoclonal antibodies (MAbs) MM4.17 and MRK-16, which recognize 2 different epitopes of the drug efflux pump molecule. ...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910590614

    authors: Molinari A,Cianfriglia M,Meschini S,Calcabrini A,Arancia G

    更新日期:1994-12-15 00:00:00

  • PBX3 is a putative biomarker of aggressive prostate cancer.

    abstract::There is a great need to identify new and better prognostic and predictive biomarkers to stratify prostate cancer patients for optimal treatment. The aims of this study were to characterize the expression profile of pre-B cell leukemia homeobox (PBX) transcription factors in prostate cancer with an emphasis on investi...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.30220

    authors: Ramberg H,Grytli HH,Nygård S,Wang W,Ögren O,Zhao S,Løvf M,Katz B,Skotheim RI,Bjartell A,Eri LM,Berge V,Svindland A,Taskén KA

    更新日期:2016-10-15 00:00:00

  • Transperineal brachytherapy in patients with large prostate glands.

    abstract::The purpose of this study is to help clarify the use of prostate size as a selection factor for prostate brachytherapy. From 1997 to 1998, 33 patients with a TRUS-based prostate volume greater than 50 cc were treated at the University of Washington by I-125 (144 Gy) or Pd-103 (115 Gy) implantation for prostatic carcin...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:

    authors: Wang H,Wallner K,Sutlief S,Blasko J,Russell K,Ellis W

    更新日期:2000-08-20 00:00:00

  • Use of cyclin D1 in conjunction with human papillomavirus status to predict outcome in oropharyngeal cancer.

    abstract::There is increasing use of multiple molecular markers to predict prognosis in human cancer. Our aim was to examine the prognostic significance of cyclin D1 and retinoblastoma (pRb) expression in association with human papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma. Clinical records and specimens ...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.25479

    authors: Hong AM,Dobbins TA,Lee CS,Jones D,Fei J,Clark JR,Armstrong BK,Harnett GB,Milross CG,Tran N,Peculis LD,Ng C,Milne AG,Loo C,Hughes LJ,Forstner DF,O'Brien CJ,Rose BR

    更新日期:2011-04-01 00:00:00

  • The value of the 1981 WHO histological classification in inter-observer reproducibility and changing pattern of lung cancer.

    abstract::A series of 722 lung carcinomas, surgically resected and typed some years ago according to the 1967 WHO classification, was independently reviewed by 2 observers in order to test the reproducibility of histopathological typing when using the criteria of the 1981 WHO classification. Typing was fully agreed upon in 87% ...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910530205

    authors: Campobasso O,Andrion A,Ribotta M,Ronco G

    更新日期:1993-01-21 00:00:00

  • Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development.

    abstract::Fibroblast growth factor 15 (FGF15), FGF19 in humans, is a gut-derived hormone and a key regulator of bile acids and carbohydrate metabolism. FGF15 also participates in liver regeneration after partial hepatectomy inducing hepatocellular proliferation. FGF19 is overexpressed in a significant proportion of human hepato...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.29287

    authors: Uriarte I,Latasa MU,Carotti S,Fernandez-Barrena MG,Garcia-Irigoyen O,Elizalde M,Urtasun R,Vespasiani-Gentilucci U,Morini S,de Mingo A,Mari M,Corrales FJ,Prieto J,Berasain C,Avila MA

    更新日期:2015-05-15 00:00:00

  • Genetic features of multicentric/multifocal intramucosal gastric carcinoma.

    abstract::Chronic gastritis caused by Helicobacter pylori (H. pylori) infection could lead to the development of gastric cancer. The finding that multiple gastric cancers can develop synchronously and/or metachronously suggests the development of field cancerization in chronically inflamed, H. pylori-infected gastric mucosa. Th...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.31578

    authors: Mizuguchi A,Takai A,Shimizu T,Matsumoto T,Kumagai K,Miyamoto S,Seno H,Marusawa H

    更新日期:2018-10-15 00:00:00

  • Colorectal cancer survival in the Nordic countries and the United Kingdom: excess mortality risk analysis of 5 year relative period survival in the period 1999 to 2000.

    abstract::A deficit in colorectal cancer survival in Denmark and in the UK compared to Sweden, Norway and Finland was found in the EUROCARE studies. We set out to explore if these differences still exist. Patients diagnosed with colorectal cancer as their first invasive cancer at age 15-89 in the period 1994-2000 were identifie...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.22737

    authors: Engholm G,Kejs AM,Brewster DH,Gaard M,Holmberg L,Hartley R,Iddenden R,Møller H,Sankila R,Thomson CS,Storm HH

    更新日期:2007-09-01 00:00:00

  • The international classification of childhood cancer.

    abstract::The International Classification of Childhood Cancer (ICCC) updates the widely used Birch and Marsden classification scheme. ICCC is based on the second edition of the International Classification of Diseases for Oncology (ICD-O-2). The purpose of the new classification is to accommodate important changes in recogniti...

    journal_title:International journal of cancer

    pub_type: 杂志文章,评审

    doi:10.1002/(SICI)1097-0215(19961211)68:6<759::AID-IJC

    authors: Kramárová E,Stiller CA

    更新日期:1996-12-11 00:00:00

  • Prenatal exposure of mice to the human liver carcinogen aflatoxin B1 reveals a critical window of susceptibility to genetic change.

    abstract::It has become axiomatic that critical windows of susceptibility to genotoxins exist and that genetic damage in utero may be a trigger for later life cancers. Data supporting this critical window hypothesis are remarkably few. This study provides a quantitative bridge between DNA damage by the liver carcinogen aflatoxi...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.29102

    authors: Chawanthayatham S,Thiantanawat A,Egner PA,Groopman JD,Wogan GN,Croy RG,Essigmann JM

    更新日期:2015-03-15 00:00:00

  • In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer.

    abstract::We recently reported the potential of genistein in augmenting gemcitabine-induced killing of pancreatic cancer (Banerjee, S. et al., Cancer Research 2005;65:9064-72). Since cis-diaminedichloroplatinum (II) (cisplatin) is widely used against solid tumors, we further investigated whether genistein pretreatment could be ...

    journal_title:International journal of cancer

    pub_type: 杂志文章,收录出版

    doi:10.1002/ijc.22332

    authors: Banerjee S,Zhang Y,Wang Z,Che M,Chiao PJ,Abbruzzese JL,Sarkar FH

    更新日期:2007-02-15 00:00:00

  • Further characterization of a herpesvirus-positive orang-utan cell line and comparative aspects of in vitro transformation with lymphotropic old world primate herpesviruses.

    abstract::An orang-utan (Pongo pygmaeus) suspension line, CP81, was shown to lack myeloid markers of lysozyme activity an d phagocytosis but to be positive for lymphocytic N-alkaline phosphatase activity, and to release a B-cell-tropic herpesvirus. This herpesvirus, termed Herpesvirus pongo, had 30--40% DNA homology with EBV an...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910210614

    authors: Rabin H,Neubauer RH,Hopkins RF 3rd,Nonoyama M

    更新日期:1978-06-15 00:00:00

  • Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. III. Inhibition of growth and necrosis of tumors implanted subcutaneously.

    abstract::Administration of highly purified interferon to DBA/2 mice inhibited the growth of interferon-sensitive or interferon-resistant Friend erythroleukemia cells implanted subcutaneously. Injection of interferon at the site of tumor inoculation was more effective than injection of interferon intraperitoneally. Histologic e...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910310518

    authors: Belardelli F,Gresser I,Maury C,Duvillard P,Prade M,Maunoury MT

    更新日期:1983-05-15 00:00:00

  • Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer.

    abstract::We have quantified the expression of all 4 isoforms of vascular endothelial growth factor (VEGF) mRNA in non-small-cell lung cancer (NSCLC) using a new kinetic quantitative PCR method, real-time quantitative (RTQ) RT-PCR, and investigated the association between VEGF expression at the mRNA and protein levels and the c...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0215(20001120)89:6<475::aid-ijc2>3.0.

    authors: Yuan A,Yu CJ,Chen WJ,Lin FY,Kuo SH,Luh KT,Yang PC

    更新日期:2000-11-20 00:00:00

  • Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer.

    abstract::The enhanced oncogenicity of particular human papillomavirus type 16 (HPV16) E6 variants is population-dependent, implying the involvement of additional genetic cofactors. This study was designed to investigate the association between E6 variants and human leukocyte antigen (HLA) polymorphism within a Japanese populat...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.11332

    authors: Matsumoto K,Yasugi T,Nakagawa S,Okubo M,Hirata R,Maeda H,Yoshikawa H,Taketani Y

    更新日期:2003-10-10 00:00:00

  • Castration induces autoantibody and T cell responses that correlate with inferior outcomes in an androgen-dependent murine tumor model.

    abstract::We recently reported that hormone therapy induces antigen-specific autoantibody responses in prostate cancer patients. However, the contribution of autoantibody responses to clinical outcomes is unknown. We used an animal model to test the hypothesis that hormone therapy-induced immune responses may be associated with...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.24673

    authors: Hahn S,Nesslinger NJ,Drapala RJ,Bowden M,Rennie PS,Pai HH,Ludgate C,Nelson BH

    更新日期:2009-12-15 00:00:00

  • Serum concentration of thyroid hormones in abnormal and euthyroid ranges and breast cancer risk: A cohort study.

    abstract::The impact of variations in serum thyroid hormone concentration within the euthyroid range on breast cancer risk remains unclear. We investigated the effect of serum thyrotropin (TSH) and thyroid hormone concentration on breast cancer risk. This cohort study involved 62,546 Korean women, aged ≥40 years, who were free ...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.32283

    authors: Kim EY,Chang Y,Lee KH,Yun JS,Park YL,Park CH,Ahn J,Shin H,Ryu S

    更新日期:2019-12-15 00:00:00

  • Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women.

    abstract::Experimental and epidemiological data support a role for sex steroid hormones in the pathogenesis of endometrial cancer. The associations of pre-diagnostic blood concentrations of estradiol, estrone, testosterone, androstenedione, DHEAS and SHBG with endometrial cancer risk were investigated. A case-control study was ...

    journal_title:International journal of cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/ijc.11529

    authors: Lukanova A,Lundin E,Micheli A,Arslan A,Ferrari P,Rinaldi S,Krogh V,Lenner P,Shore RE,Biessy C,Muti P,Riboli E,Koenig KL,Levitz M,Stattin P,Berrino F,Hallmans G,Kaaks R,Toniolo P,Zeleniuch-Jacquotte A

    更新日期:2004-01-20 00:00:00

  • Expression of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in benign, borderline, malignant primary and metastatic ovarian tumors.

    abstract::Elevated levels of expression of the urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 have shown to be related to poor prognosis in a variety of cancer types. In the present study, cytosolic levels of uPA and PAI-1 were determined with enzyme-linked immunosorbent assays in cytosols prepared from 244 ...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/(SICI)1097-0215(19961220)69:6<475::AID-IJC

    authors: van der Burg ME,Henzen-Logmans SC,Berns EM,van Putten WL,Klijn JG,Foekens JA

    更新日期:1996-12-20 00:00:00

  • Interleukin-10 expression and cytotoxic-T-cell response in Epstein-Barr-virus-associated nasopharyngeal carcinoma.

    abstract::Interleukin-10 (IL-10) is an inhibitory cytokine produced by various cell types. It exhibits strong sequence homology to BCRF-1 (viral IL-10, vIL-10), an open reading frame in the Epstein-Barr-virus (EBV) genome. Using in situ hybridization (ISH), polymerase chain reaction (PCR) and immunohistochemistry, we checked 41...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0215(19970729)72:3<398::aid-ijc

    authors: Yao M,Ohshima K,Suzumiya J,Kume T,Shiroshita T,Kikuchi M

    更新日期:1997-07-29 00:00:00

  • Cell cycle-related kinase supports ovarian carcinoma cell proliferation via regulation of cyclin D1 and is a predictor of outcome in patients with ovarian carcinoma.

    abstract::Our previous study has suggested that the cell cycle-related kinase (CCRK) is a putative candidate oncogene in glioblastoma tumorigenesis. The potential oncogenic role of CCRK and its clinical/prognostic significance, however, in ovarian carcinoma are unclear. In this study, CCRK expression was examined by immunohisto...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.24630

    authors: Wu GQ,Xie D,Yang GF,Liao YJ,Mai SJ,Deng HX,Sze J,Guan XY,Zeng YX,Lin MC,Kung HF

    更新日期:2009-12-01 00:00:00

  • Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis.

    abstract::A "divergent pathway" model for the development of cutaneous melanoma has been proposed. The model hypothesizes that melanomas occurring in people with a low tendency to develop nevi will, on average, arise more commonly on habitually sun-exposed body sites such as the head and neck. In contrast, people with an inhere...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.24011

    authors: Olsen CM,Zens MS,Stukel TA,Sacerdote C,Chang YM,Armstrong BK,Bataille V,Berwick M,Elwood JM,Holly EA,Kirkpatrick C,Mack T,Bishop JN,Østerlind A,Swerdlow AJ,Zanetti R,Green AC,Karagas MR,Whiteman DC

    更新日期:2009-02-15 00:00:00

  • Improving identification of lynch syndrome patients: a comparison of research data with clinical records.

    abstract::Current evidence suggests poor identification and referral of Lynch syndrome patients. This study evaluated the strategies by which patients with endometrial cancer were referred to genetics services. Data from clinic-based patients with endometrial cancer enrolled through the Australian National Endometrial Cancer po...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.27978

    authors: Tan YY,McGaughran J,Ferguson K,Walsh MD,Buchanan DD,Young JP,Webb PM,Obermair A,Spurdle AB,ANECS Group.

    更新日期:2013-06-15 00:00:00

  • Characterization of a lung-cancer-associated auto-antigen.

    abstract::An antigen, protein X (Px), was purified from immune complexes isolated from malignant pleural effusions from patients with adenocarcinoma of the lung by EDTA treatment, PEG 8000 precipitation, protein A affinity chromatography, and Sephadex G-200 separation in the presence of 3 M NaCl. The purified antigen had a M(r)...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910520404

    authors: Zeng CQ,Alpert LC,Alpert E

    更新日期:1992-10-21 00:00:00

  • Resistance-associated factors in human small-cell lung-carcinoma GLC4 sub-lines with increasing adriamycin resistance.

    abstract::Previous studies have shown that the in vitro-selected adriamycin-resistant human small-cell lung-carcinoma cell line GLC4-ADR150 displays multidrug resistance as the result of 3-fold decreased DNA-topoisomerase II (topo II) activity and a 6-fold reduction in adriamycin accumulation. Not the MDR1 gene, but the MRP gen...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910610317

    authors: Versantvoort CH,Withoff S,Broxterman HJ,Kuiper CM,Scheper RJ,Mulder NH,de Vries EG

    更新日期:1995-05-04 00:00:00